Posts Tagged ‘clinical trials’

It is no surprise that the roadmap for Vice President Biden’s Cancer “Moonshot” revolves around technology and data sharing. As part of his cancer “moonnshot”, Vice President Joe Biden pledged to work to increase cancer research resources and improve coordination across the research community. In a recent post on Medium , Biden said breaking down […]

  The life sciences industry could learn a little something from Southwest Airlines’ “Transfarency” campaign, in terms of reporting clinical trial results. A recent investigation by the publication STAT found significant violations in the reporting of clinical trial results to the ClinicalTrials.gov database. Most academic research institutions, drug companies, and even the National Institutes of […]

  Last week, I wrote that Vice President Joe Biden was going to meet with cancer researchers to talk about regulatory questions revolving around precision medicine. Today, we know much more about the cancer “moonshot” President Obama charged Biden with in this week’s State of the Union address. In a post on the publishing platform […]

  Now that January is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in December – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Demographics in clinical trials have always been scrutinized by the medical community and the public. Are various races, ethnicities, sexes, and ages fairly represented in trials? Does one segment respond better or worse than another to a particular treatment? These questions and more are being answered in Drug Trials Snapshots, a section of the […]

  In an article from Clinical Leader, Chief Editor, Ed Miseta, and Bayer Healthcare’s VP Global Strategy & Development Advisor, Johann Proeve, discuss using electronic health record (EHR) and electronic data capture (EDC) systems to lower the overall costs of running clinical trials. 

  Gordon Ritter, co-founder and general partner of Emergence Capital, wrote an article in TechCrunch the day after Thanksgiving in which he spoke about the prowess of “industry cloud companies” – companies that develop software for specific verticals. “These companies might not be well-known outside specific industries, but ask anyone within an industry vertical and […]

  Clinical trials face long delays and, in some cases, are even cancelled because too few subjects are enrolled. Sponsors and CROs have different recruitment strategies, from advertising through mainstream media (although this practice is not as widespread you’d think) to the use of mobile and digital applications. But, one of the most effective ways […]

  Now that December is here, I thought it would be neat to look back at what our readers found most interesting last month. Below are the top five blog posts Perficient’s life sciences practice wrote in November – they’re ranked in order of popularity, with number one being the most viewed piece. 

  Last month, Perficient attended the Oracle OpenWorld conference and presented at several sessions. One of those sessions was on how clinical trial management systems (CTMS) can support risk-based monitoring (RBM) strategies at life sciences companies. 

  Over the last decade, the life sciences industry has gone from running clinical trials on paper or, in many cases, in Excel, to leveraging comprehensive web-based systems, such as electronic data capture (EDC) and clinical trial management systems (CTMS). But, in more recent years, the widespread use of mobile technology has enabled even more […]

  In honor of Veterans Day, I thought it would be worth sharing a program that’s geared toward our beloved military veterans, yet helps society as a whole.